These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 26608090)

  • 1. Epidemiology and factors associated with candidaemia following Clostridium difficile infection in adults within metropolitan Atlanta, 2009-2013.
    Vallabhaneni S; Almendares O; Farley MM; Reno J; Smith ZT; Stein B; Magill SS; Smith RM; Cleveland AA; Lessa FC
    Epidemiol Infect; 2016 May; 144(7):1440-4. PubMed ID: 26608090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors and clinical outcomes of candidaemia in patients treated for Clostridium difficile infection.
    Russo A; Falcone M; Fantoni M; Murri R; Masucci L; Carfagna P; Ghezzi MC; Posteraro B; Sanguinetti M; Venditti M
    Clin Microbiol Infect; 2015 May; 21(5):493.e1-4. PubMed ID: 25698658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in treatment of community-onset Clostridioides difficile infection after release of updated guidelines, Atlanta, Georgia, 2018.
    Adelman MW; Goodenough D; Sefton S; Mackey C; Thomas S; Fridkin SK; Woodworth MH
    Anaerobe; 2021 Aug; 70():102364. PubMed ID: 33862203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors and outcomes of Clostridium difficile infection in hospitalized patients.
    Lee HY; Hsiao HL; Chia CY; Cheng CW; Tsai TC; Deng ST; Chen CL; Chiu CH
    Biomed J; 2019 Apr; 42(2):99-106. PubMed ID: 31130254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does Addition of Intravenous Metronidazole to Oral Vancomycin Improve Outcomes in Clostridioides difficile Infection?
    Wang Y; Schluger A; Li J; Gomez-Simmonds A; Salmasian H; Freedberg DE
    Clin Infect Dis; 2020 Dec; 71(9):2414-2420. PubMed ID: 31714955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Updates in the epidemiology and management of candidemia and
    Falcone M; Tiseo G; Venditti M; Menichetti F
    Expert Rev Anti Infect Ther; 2019 May; 17(5):375-382. PubMed ID: 30982376
    [No Abstract]   [Full Text] [Related]  

  • 7. Clostridium difficile: A Frequent Infection in Children After Intestinal Transplantation.
    Duclaux-Loras R; Berthiller J; Ferroni A; Chardot C; Goulet O; Lacaille F; Norsa L
    Transplantation; 2020 Jan; 104(1):197-200. PubMed ID: 31205257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ridinilazole: a novel, narrow-spectrum antimicrobial agent targeting Clostridium (Clostridioides) difficile.
    Collins DA; Riley TV
    Lett Appl Microbiol; 2022 Sep; 75(3):526-536. PubMed ID: 35119124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An outbreak of Clostridium difficile PCR ribotype 027 in Spain: risk factors for recurrence and a novel treatment strategy.
    Bouza E; Alcalá L; Marín M; Valerio M; Reigadas E; Muñoz P; González-Del Vecchio M; de Egea V
    Eur J Clin Microbiol Infect Dis; 2017 Oct; 36(10):1777-1786. PubMed ID: 28501926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of first recurrence of Clostridium difficile infection: fidaxomicin versus vancomycin.
    Cornely OA; Miller MA; Louie TJ; Crook DW; Gorbach SL
    Clin Infect Dis; 2012 Aug; 55 Suppl 2(Suppl 2):S154-61. PubMed ID: 22752865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of Oral Vancomycin for Clostridioides difficile Infection and the Risk of Vancomycin-Resistant Enterococci.
    Stevens VW; Khader K; Echevarria K; Nelson RE; Zhang Y; Jones M; Timbrook TT; Samore MH; Rubin MA
    Clin Infect Dis; 2020 Jul; 71(3):645-651. PubMed ID: 31504328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes associated with recent guideline recommendations removing metronidazole for treatment of non-severe Clostridioides difficile infection: a retrospective, observational, nationwide cohort study.
    Gentry CA; Campbell DL; Williams RJ
    Int J Antimicrob Agents; 2021 Mar; 57(3):106282. PubMed ID: 33465458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential impact of removing metronidazole from treatment armamentarium of mild acute
    Zilberman-Itskovich S; Youngster I; Lazarovitch T; Bondarenco M; Toledano L; Kachlon Y; Mengesha B; Strul N; Zaidenstein R; Marchaim D
    Future Microbiol; 2019 Nov; 14():1489-1495. PubMed ID: 31913060
    [No Abstract]   [Full Text] [Related]  

  • 14. Oral vancomycin versus metronidazole for the treatment of Clostridioides difficile infection: Meta-analysis of randomized controlled trials.
    Igarashi Y; Tashiro S; Enoki Y; Taguchi K; Matsumoto K; Ohge H; Suzuki H; Nakamura A; Mori N; Morinaga Y; Yamagishi Y; Yoshizawa S; Yanagihara K; Mikamo H; Kunishima H
    J Infect Chemother; 2018 Nov; 24(11):907-914. PubMed ID: 30170735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral Vancomycin Monotherapy Versus Combination Therapy in Solid Organ Transplant Recipients With Uncomplicated Clostridium difficile Infection: A Retrospective Cohort Study.
    Korayem GB; Eljaaly K; Matthias KR; Zangeneh TT
    Transplant Proc; 2018; 50(1):137-141. PubMed ID: 29407296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vancomycin, metronidazole, or tolevamer for Clostridium difficile infection: results from two multinational, randomized, controlled trials.
    Johnson S; Louie TJ; Gerding DN; Cornely OA; Chasan-Taber S; Fitts D; Gelone SP; Broom C; Davidson DM;
    Clin Infect Dis; 2014 Aug; 59(3):345-54. PubMed ID: 24799326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Trend for Antibiotic Use for Clostridioides (Clostridium) difficile Infection in Japan.
    Ishii S; Muraki Y; Kusama Y; Yagi T; Goto R; Ebisui A; Kawabe A; Inose R; Ohmagari N
    Biol Pharm Bull; 2020; 43(4):693-696. PubMed ID: 32238711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk Factors and Outcomes for Bloodstream Infections Secondary to Clostridium difficile Infection.
    Falcone M; Russo A; Iraci F; Carfagna P; Goldoni P; Vullo V; Venditti M
    Antimicrob Agents Chemother; 2016 Jan; 60(1):252-7. PubMed ID: 26482315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcome of Clostridioides difficile infections treated in a Swiss tertiary care hospital: an observational study.
    Haubitz S; Bartlomé N; Bucheli Laffer E; Spelters C; Fankhauser H; Fux CA
    Swiss Med Wkly; 2020 Jan; 150():w20173. PubMed ID: 31940431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Defining the vulnerable period for re-establishment of Clostridium difficile colonization after treatment of C. difficile infection with oral vancomycin or metronidazole.
    Abujamel T; Cadnum JL; Jury LA; Sunkesula VC; Kundrapu S; Jump RL; Stintzi AC; Donskey CJ
    PLoS One; 2013; 8(10):e76269. PubMed ID: 24098459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.